Results 281 to 290 of about 398,844 (320)

CD98 heavy chain protein is overexpressed in non-small cell lung cancer and is a potential target for CAR T-cell therapy. [PDF]

Sci Rep
Yaga M, Hasegawa K, Ikeda S, Matsubara M, Hiroshima T, Kimura T, Shirai Y, Tansri W, Uehara H, Tachikawa M, Okairi Y, Sone M, Mori H, Kogue Y, Akamine H, Okuzaki D, Kawagishi K, Kawanaka S, Yamato H, Takeuchi Y, Okura E, Kanzaki R, Okami J, Nakamichi I, Nakane S, Kobayashi A, Iwazawa T, Tokunaga T, Yokouchi H, Yano Y, Uchida J, Mori M, Komuta K, Tachi T, Kuroda H, Kijima N, Kishima H, Ichii M, Futami S, Naito Y, Shiroyama T, Miyake K, Koyama S, Hirata H, Takeda Y, Funaki S, Shintani Y, Kumanogoh A, Hosen N.   +48 more
europepmc   +1 more source

The immunoglobulin heavy chain super enhancer controls class switch recombination in developing B cells. [PDF]

Sci Rep
Dauba A, Näser E, Andrieux D, Cogné M, Denizot Y, Khamlichi AA.   +5 more
europepmc   +1 more source

Primary adrenal insufficiency developed 22 years after the diagnosis of light and heavy chain deposition disease: a case report. [PDF]

CEN Case Rep
Eguchi E.
europepmc   +1 more source

Recombinant Human Heavy Chain Ferritin Nanoparticles Serve as ROS Scavengers for the Treatment of Ischemic Stroke. [PDF]

Int J Nanomedicine
Qi M, Cheng Y, Liu K, Cai J, Liu T, Wu X, Tang H, Huang H, Chen Q, Zhou X.   +9 more
europepmc   +1 more source

Heavy-chain diseases [PDF]

Hematology/Oncology Clinics of North America, 1999
This review underscores the diversity of the structural and genetic abnormalities of HCD proteins and of the clinicopathologic features of the underlying lymphoproliferative disorders. Cells producing HCD may, however, all derive from a common normal precursor, which could be a rare B cell in the process of immunoglobulin gene somatic mutation within ...
DIMOPOULOS, MELETIOS A, MOULOPOULOS, LIAA   +1 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Heavy chain diseases

Best Practice & Research Clinical Haematology, 2005
Heavy chain diseases (HCDs) are rare B-cell lymphoplasma-cell proliferative disorders characterized by production of truncated monoclonal immunoglobulin heavy chains without associated light chains. HCDs involving the three main immunoglobulin classes have been described; alpha-HCD is the most common and has the most uniform presentation, gamma- and mu-
Dietlind L. Wahner-Roedler, Robert A. Kyle   +1 more
openaire   +3 more sources

Heavy Chain Disease

Archives of Internal Medicine, 1972
To the Editor. —We read with interest the paper in the September issue1 on αheavy chain disease in which the pathological immunoglobulin disappeared with chemotherapy. The authors state that up to the time of acceptance of their paper all cases of so-called Mediterranean lymphoma and α-chain disease have occurred either in Arabs or oriental Jews in ...
S. Bank, B. H. Novis
openaire   +3 more sources